Medical Science Liaison, Liver Disease- Upper Midwest Territory at Gilead Sciences

Minneapolis, Minnesota, United States

Apply Now

Not SpecifiedCompensation

Mid-level (3 to 4 years), Senior (5 to 8 years)Experience Level

Full TimeJob Type

UnknownVisa

Pharmaceuticals, Biotechnology, HealthcareIndustries

Requirements

Basic Qualifications: 8+ Years with BS OR 6+ Years with MS OR 2+ Years with PhD/PharmD OR 0+ Years with MD
Preferred: Advanced medical/scientific/clinical degree (MD, DO, PhD, PharmD, NP/PA preferred) with experience in the pharmaceutical industry or related healthcare field
Preferred: A minimum 0-3 years of relevant experience in a medically related profession (e.g., liver disease and/or)

Responsibilities

Deliver timely, accurate, and succinct clinical, scientific, and educational presentations to healthcare providers in liver disease, both proactively and in response to requests for information, consistent with promotional compliance, PhRMA guidelines, and FDA regulatory requirements
Implement defined goals and objectives aligned with the Medical Affairs Plan of Action and other strategic initiatives for PBC, HCV and HBV
Develop strategic plans for cultivating and maintaining working relationships with existing and future thought leaders in the assigned region
Provide timely insights to the strategy and competitive intelligence teams regarding treatment practice and trends observed in field interactions
Evaluate existing Gilead promotional speakers, and nominates HCPs to serve as new or continuing speakers each year
Participate in advisory boards and educational programs, including speaker training sessions and clinical conferences
Collaborate appropriately with colleagues across other functional areas, including Global Medical Affairs, Clinical Research, Clinical Operations, Strategic Operations, Government and Public Affairs, Commercial, and Marketing
Support the development, deployment, and appropriate use of field tools and resources (e.g., slide decks)
Interact with clinical research principal investigators (PIs) and their staff as needed to follow up on clinical trial issues, and support Investigator Sponsored Research
Provide scientific training to sales staff and other Gilead colleagues, as needed
Complete required administrative and training procedures in a timely fashion (e.g., required policy and learning modules, expense reports, documentation of healthcare provider interactions, etc.)
Adhere to all applicable pharmaceutical codes, Office of Inspector General (OIG) guidelines, and Gilead policies

Skills

Medical Science Liaison

Liver Disease

Primary Biliary Cholangitis

PBC

Hepatitis C

HCV

Hepatitis B

HBV

Clinical Presentations

Scientific Communication

Educational Presentations

PhRMA Guidelines

Healthcare Providers

Gilead Sciences

Develops and commercializes biopharmaceuticals

About Gilead Sciences

Gilead Sciences focuses on discovering, developing, and commercializing medicines for various medical conditions, including HIV/AIDS, liver diseases, cancer, inflammatory and respiratory diseases, and cardiovascular issues. The company conducts extensive research and development to create new therapies, which are then marketed to healthcare providers, hospitals, and pharmacies after receiving regulatory approval. Gilead differentiates itself from competitors through its strong commitment to R&D and strategic partnerships, such as with SAP Ariba, to enhance its operations and product offerings. The company's goal is to improve health equity and access to care globally, working with communities to ensure that its medicines reach those in need.

Foster City, CaliforniaHeadquarters

1987Year Founded

$15,873.6MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Benefits

Paid family time off and paid parental time off

Generous 401(k) contribution matching

Comprehensive medical plans that cover both physical and mental healthcare

Global Wellbeing Reimbursement

Time Off

Global Volunteer Day

Giving Together Program

Employee Support Programs

Flexible Work Options

Risks

Increased competition in HIV treatment from ViiV Healthcare's expanding drug portfolio.

Regulatory scrutiny over drug pricing could impact Gilead's U.S. market operations.

Patent expirations, like Truvada's, lead to increased generic competition and revenue loss.

Differentiation

Gilead's lenacapavir is recognized as the 2024 Breakthrough of the Year for HIV care.

Partnerships with LEO Pharma and Tubulis enhance Gilead's focus on inflammatory and cancer therapies.

Gilead's commitment to health equity initiatives like COMPASS and HepConnect sets it apart.

Upsides

Gilead's strategic partnerships expand its reach in inflammatory and oncology drug markets.

Investment in digital health technologies enhances Gilead's R&D and patient engagement.

Focus on sustainability improves Gilead's operational efficiency and corporate reputation.

Land your dream remote job 3x faster with AI

Try Jobo Free